Silver Book Fact

Visual loss from subfoveal choroidal neovascularization, a characteristic of wet age-related macular degeneration (AMD), was found to have a profound impact on how patients felt about their health-related quality of life–rating it as low or lower than patients with renal failure and AIDS.

Bass, Eric B., Marta J. Marsh, Carol M. Mangione, Neil M. Bressler, Ashley L. Childs, Li Ming Dong, Barbara S. Hawkins, Harris A. Jaffee, and Paiva H. Miskala. Patients’ Perceptions of the Value of Current Vision: Assessment of preference values among patients with subfoveal choroidal neovascularization– The Submacular Surgery Trials Vision Preference Value Scale. Arch Opthalmol. 2004; 122(12): 1856-67. http://archopht.ama-assn.org/cgi/content/abstract/122/12/1856

Reference

Title
Patients’ Perceptions of the Value of Current Vision: Assessment of preference values among patients with subfoveal choroidal neovascularization– The Submacular Surgery Trials Vision Preference Value Scale
Publication
Arch Opthalmol
Publication Date
2004
Authors
Bass, Eric B., Marta J. Marsh, Carol M. Mangione, Neil M. Bressler, Ashley L. Childs, Li Ming Dong, Barbara S. Hawkins, Harris A. Jaffee, and Paiva H. Miskala
Volume & Issue
Volume 122, Issue 12
Pages
1856-67
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Related Facts

  • The number of people in the U.S. with visual impairment or blindness is expected to double to more than 8 million by 2050.
     
  • Number of Patients Aged 40 to 64 Using Medical Services, Medications and Vitamins  
  • Estimated Age-Specific Prevalence Rates for Vision Impairment  
  • Glaucoma is almost 3 times more common in African Americans than in whites.  
  • The number of cases of early age-related macular degeneration (AMD) is projected to increase from 9.1 million in 2010 to 17.8 million in 2050.